Bioavailability of recombinant human growth hormone in different concentrations and formulations

Pharmacology and Toxicology

Volumn 79, Issue 3, 1996, Pages 144-149

  Vahl, Nina ^a,d   Jensen, Simone B ^b   Rasmussen, Michael H ^b   Susgaard, Søren ^c   Jørgensen, Jens O L ^a   Christiansen, Jens S ^a   Rasmussen, Ulla F ^e   Hilsted, Jannik ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NOVO NORDISK A S   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; ARTICLE; BIOAVAILABILITY; BIOEQUIVALENCE; CLINICAL ARTICLE; DRUG FORMULATION; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0029907911     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00258.x     Document Type: Article

References (15)

1. Albertsson-Wikland, K., O. Westphal & U. Westgren: Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta paediatr. scand. 1986, 75, 89-97.
2. Albertsson-Wikland, K.: Simplified growth hormone therapy First clinical experience with the KubiPen. Acta Paediart. Scand. 1988, 343, suppl. 103-106.
3. Blok, G. J., E. A. Van der Veen, S. Susgaard & F. Larsen: Influence of concentration and injection volume on the bioavailability of subcutaneous GH. Comparison of administration by ordinary syringe and by injection pen. Pharmacology & Toxicology 1991, 68, 355-359.
4. Christiansen, J. S., H. Ørskov, C. Binder, K. W. Kastrup: Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children. Acta Endocrinol. 1983, 102, 6-10.
5. Food and Drug Administration, Division for Bioequivalence: Guidance. Statistical procedures for bioequivalence studies using a standard two-treatment crossover design. 1992, 1-12.
6. Jørgensen J. O. L., J. Møller, F. S. Jensen, J. T. Jørgensen, J. S. Christiansen: GH administration by means of an injection pen. Pharmacology & Toxicology 1989b, 65, 96-99.
7. Jørgensen J. O. L., S. A. Pedersen, L. Thuesen, J. Jørgensen, T. Ingemann-Hansen, N. E. Skakkebæk. J. S. Christiansen: Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989a, 166, 1221-1225.
8. Jørgensen, J. O. L., S. A. Pedersen, L. Thuesen, J. Jørgensen, J. Møller, J. Müller, N. E. Skakkebæk & J. S. Christiansen: Long-term growth hormone treatment in growth hormone deficient adults. Acta endocrinol. (Copenh.) 1991, 125, 449-453.
9. Kastrup, K. W., J. S. Christiansen, J. K. Andersen & H. Ørskov: Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in GHD children. Acta endocrinol. (Copenh) 1983, 104, 148-152.
10. Laursen, T., J. O. L. Jørgensen, S. Susgaard, J. Møller & J. S. Christiansen: Subcutaneous absorption kinetics of two highly concentrated preparations of recombinant human growth hormone (hGH). Ann. Pharmacotherap. 1993, 27, 411-415.
11. Laursen, T., S. Susgaard, F. S. Jensen, J. O. L. Jørgensen & J. S. Christiansen: Absorption kinetics of two highly concentrated preparations of growth hormone: 12 IU/ml compared to 56 IU/ ml. Pharmacology & Toxicology 1994, 74, 54-57.
12. Salomon, F., R. C. Cuneo, R. Hesp & P. H. Sönksen: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 1989, 321, 1797-1803.
13. Schuirmann, D. J.: A comparison of the two one-sided test procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokin. Biopharm. 1987, 15, 657-680.
14. Susgaard, S.: The influence of different concentrations of biosynthetic human growth hormone on GH bioavailability. A phase II study. Final Clinical Report, revised edition Novo Nordisk A/S, November 1992.
15. Ørskov H., H. G. Thomsen & H. Yde: Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 1968, 219, 193-195.